Altogether, the B-cell Neu1 levels classified by the use of biologics were superior for the discrimination of three different improvement criteria (Figure 4, Table 7 and Supplementary Table S3), similar to RA patients as a whole (Figure 1, Table 3 and Table 4). The gene discussed is NEU1; the disease is rheumatoid arthritis.